Last reviewed: June 7, 2026
Last updated: June 7, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide, originally developed as a diabetes medication, has emerged as one of the most studied weight loss compounds in modern medicine. Clinical trials demonstrate that approximately 86% of patients using semaglutide at therapeutic doses experience meaningful weight reduction. PlexusDx delivers compounded semaglutide injections from licensed 503A pharmacies, making this proven therapy accessible across all 50 states without insurance requirements.
Clinical Trial Data on Semaglutide Weight Loss Success Rates
The STEP clinical trial program, which evaluated semaglutide in over 4,500 patients without diabetes, revealed that 86% of participants lost at least 5% of their starting body weight. At the highest studied dose, approximately 50% of patients achieved 15% or greater weight reduction—a threshold considered clinically significant by medical standards. These results remained consistent across diverse age groups, body mass index ranges, and ethnic backgrounds, suggesting broad applicability.
Individual response varies based on multiple factors including baseline metabolism, adherence to injection schedules, dietary modifications, and genetic predisposition to GLP-1 receptor sensitivity. Patients typically observe initial weight changes between weeks 4 and 8, with continued progression through 12-16 weeks as the body adapts to medication effects. The average trajectory shows 5-10% weight loss in the first 3 months, with potential additional losses through month 6.
How Semaglutide Mechanisms Drive Weight Loss Beyond Calorie Reduction
Semaglutide activates GLP-1 receptors in the brain's appetite centers, directly reducing hunger signals and increasing satiety hormones. This neurological action distinguishes it from traditional appetite suppressants because the medication works with your body's natural signaling rather than forcing restriction through willpower alone. Patients frequently report that they simply feel less compelled to eat, rather than fighting constant cravings—a crucial difference that improves long-term adherence.
The compound also slows gastric emptying, meaning food remains in the stomach longer, prolonging feelings of fullness after meals. Additionally, semaglutide improves insulin sensitivity and glucose metabolism, which can reduce energy-storage signals that typically drive weight regain after weight loss. These layered mechanisms explain why semaglutide produces more sustained results compared to older diet-based approaches.
Factors That Influence Individual Weight Loss Outcomes With Semaglutide
Genetic variations in GLP-1 receptor sensitivity significantly impact how effectively semaglutide works for each person. PlexusDx offers the Precision Peptide Genetic Test, which analyzes key variants including GLP1R rs6923761 and GIPR rs1800437—markers that influence peptide pathway activation and medication responsiveness. Testing before beginning therapy provides clarity on whether you carry genetic predispositions that favor stronger GLP-1 effects, allowing for personalized dose and compound selection.
Lifestyle factors including consistent physical activity, protein intake, and sleep quality interact with semaglutide to amplify weight loss. Patients who maintain regular exercise while using semaglutide lose more lean muscle mass compared to diet-only approaches. Adequate sleep and stress management also stabilize cortisol levels, which can otherwise interfere with metabolic improvements that semaglutide provides.
Accessing Compounded Semaglutide: Cost and Availability at PlexusDx
PlexusDx compounded semaglutide injection starts at $149 per month through licensed 503A compounding pharmacies, with pricing remaining flat regardless of dose level—meaning your dose may need to go up, but your price won't. This flat-rate model removes the financial uncertainty of dose escalation, allowing patients to adjust their treatment based on clinical need rather than cost constraints. Medications ship to all 50 states without insurance requirements, making therapy accessible regardless of employment or coverage status.
HSA and FSA accounts cover PlexusDx medications in full, providing a tax-advantaged payment pathway for eligible patients. No membership fees apply, and patients can begin therapy within days of completing a clinical consultation with licensed practitioners. For those interested in personalization, the Precision Peptide Genetic Test adds $99 after the first month of treatment, offering genetic insights that optimize long-term medication selection and dosing strategy.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
What percentage of people lose weight on semaglutide?
Clinical trials show 86% of semaglutide users achieve at least 5% weight loss, with approximately 50% reaching 15% or greater reduction at therapeutic doses. Results depend on starting weight, genetic receptor sensitivity, and adherence to both medication and lifestyle modifications. PlexusDx genetic testing can predict individual responsiveness based on GLP-1 pathway variants.
How much weight do people typically lose in the first month?
Most patients observe initial weight changes between weeks 4 and 8, averaging 5-10% reduction over the first 3 months. First-month losses vary widely because the medication requires dose escalation schedules; faster initial results occur once therapeutic doses are reached. Consistent weight tracking helps distinguish water loss from fat loss during early treatment phases.
How much does compounded semaglutide cost at PlexusDx?
PlexusDx compounded semaglutide injection costs $149 per month starting price, with your dose able to increase without price increases. All 50 states receive service without insurance requirements, and HSA/FSA accounts provide tax-advantaged payment options. Licensed 503A compounding pharmacies dispense all medications within days of consultation approval.
Are there side effects that impact weight loss results?
Common side effects including nausea and appetite changes typically resolve within 2-3 weeks as the body adapts. These effects don't prevent weight loss; rather, medication-induced appetite reduction drives the therapeutic benefit. Serious side effects are rare with properly supervised dosing, though patients with personal or family pancreatitis history require medical review before starting.
Can genetic testing predict if semaglutide will work for me?
PlexusDx Precision Peptide Genetic Test analyzes GLP1R rs6923761 and GIPR rs1800437 variants that influence receptor sensitivity and medication response. Patients with enhanced genetic signatures for GLP-1 activation typically experience stronger appetite suppression and faster weight loss. This personalized insight helps optimize compound selection—semaglutide versus tirzepatide—before beginning treatment.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
How Fast Do You Lose Weight on Compounded Semaglutide?
How Long Does Compounded Semaglutide Last in the Freezer?